Brain Tumors: Astrocytoma, Oligodendroglioma, and Glioblastoma Images with PET and SPECT Lutz W. Kracht Karl Herholz Stefan Vollmar Andreas H. Jacobs Primary brain tumors arise from different types of brain…
The Normal Brain Scan Alfred Buck Valerie Treyer Bruno Weber In order to interpret clinical brain positron emission tomography (PET) scans, it is important to know the appearance of the…
Introduction Clinical positron emission tomography (PET) and single-photon emission computed tomography (SPECT) and integrated imaging of the brain combining PET or SPECT with magnetic resonance imaging (MRI) or computed tomography…
SPECT and SPECT-CT Imaging Protocols Daniela B. Husarik Thomas F. Hany Single-photon emission computed tomography–computed tomography (SPECT-CT) systems combine a SPECT gamma camera and a CT system. Depending on the…
PET and PET-CT Imaging Protocols Thomas F. Hany Standardization of PET and PET-CT imaging protocols is beneficial for optimizing image quality as well as workflow in a PET center. Fluorine…
SPECT Radiopharmaceuticals for Perfusion Imaging and Tumor and Inflammation Localization Gerrit Westera In this chapter, the SPECT radiopharmaceuticals frequently used in clinical practice are discussed. Three major classes can be…
11C-Based PET- Radiopharmaceuticals of Clinical Value Kjell Någren Christer Halldin Positron emission tomography (PET) imaging with carbon 11 (11C) radiopharmaceuticals is challenging because of the short half-life of the radionuclide…
PET Radiopharmaceuticals: Fluorinated Compounds Heinz H. Coenen Dedicated to Professor Dr. Dr. H.C. Christoph Reiners on the occasion of his 60th birthday. After short summaries of the basic features of…
PET Radiopharmaceuticals: Perfusion Compounds [13N]Ammonia, [15O]Water, [82RB]Rubidium, and Other Generator Products of Clinical Relevance Simon M. Ametamey Peter Bläuenstein P. August Schubiger Cerebral and cardiac perfusion studies by PET provide…
Radiopharmaceuticals for Clinical PET, PET-CT, and SPECT-CT Imaging Gustav K. von Schulthess Designing good radiopharmaceuticals for imaging is a more difficult task than one might think. It is therefore not…
